The US FDA may limit Covid-19 boosters to high-risk groups only, citing lack of efficacy in healthy individuals. Meanwhile, ...

Moderna (MRNA), and Novavax (NVAX) agree as the FDA advisors recommend targeting JN.1 strain for updated COVID vaccines this ...

Larry Saltzman has blood cancer. He's also a retired doctor, so he knows getting covid-19 could be dangerous for him — his ...

San Diego doctors are expressing apprehension about the new policy on COVID-19 vaccines rolled out by the U.S. Food and Drug ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

WASHINGTON (AP) — A government report released on Thursday covering wide swaths of American health and wellness reflects some ...

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

The Trump administration’s decision to revoke Harvard University’s ability to enroll international students raises ...

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...